Are you
#JCAready?
The EU Health Technology Assessment Regulation (HTA-R) is advancing through implementation phase, with the initial Joint Clinical Assessment (JCA) submissions actively underway for oncology medicines and Advanced Therapy Medicinal Products (ATMPs).
With all new orphan medicines coming into scope from 2028, and all new medicines and devices included from 2030, there is significant attention—and some urgency—around the question of what it takes to be
#JCAready.
We've developed a
comprehensive readiness assessment, now available to you to try for FREE.
Come and talk to us at stand #403 at ISPOR to find out how we can make sure you are #JCAready.
.avif)
